Prevalence of Serotype 19A Streptococcus pneumoniae among Isolates from U.S. Children in 2005-2006 and Activity of Faropenem
- 1 July 2008
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 52 (7), 2639-2643
- https://doi.org/10.1128/aac.00310-08
Abstract
Of 393 isolates of Streptococcus pneumoniae from U.S. children collected in 2005-2006, nonvaccine serotypes accounted for 89.1%, with serotype 19A the most prevalent, representing 30.5% of all isolates. The MIC 90 of faropenem against serotype 19A isolates was 1 μg/ml, compared to ≥8 μg/ml against amoxicillin/clavulanate, cefdinir, cefuroxime axetil, and azithromycin.Keywords
This publication has 24 references indexed in Scilit:
- Incidence of macrolide resistance in Streptococcus pneumoniae after introduction of the pneumococcal conjugate vaccine: population-based assessmentThe Lancet, 2005
- Reduction in High Rates of Antibiotic-Nonsusceptible Invasive Pneumococcal Disease in Tennessee after Introduction of the Pneumococcal Conjugate VaccineClinical Infectious Diseases, 2004
- Postlicensure Surveillance for Pneumococcal Invasive Disease After Use of Heptavalent Pneumococcal Conjugate Vaccine in Northern California Kaiser PermanenteThe Pediatric Infectious Disease Journal, 2004
- Decrease of Invasive Pneumococcal Infections in Children Among 8 Children’s Hospitals in the United States After the Introduction of the 7-Valent Pneumococcal Conjugate VaccinePediatrics, 2004
- Susceptibilities to Levofloxacin in Streptococcus pneumoniae , Haemophilus influenzae , and Moraxella catarrhalis Clinical Isolates from Children: Results from 2000-2001 and 2001-2002 TRUST Studies in the United StatesAntimicrobial Agents and Chemotherapy, 2003
- Decline in Invasive Pneumococcal Disease after the Introduction of Protein–Polysaccharide Conjugate VaccineNew England Journal of Medicine, 2003
- Pneumococcal Conjugate Vaccine Serotypes ofStreptococcus pneumoniaeIsolates and the Antimicrobial Susceptibility of Such Isolates in Children with Otitis MediaClinical Infectious Diseases, 2001
- Policy Statement: Recommendations for the Prevention of Pneumococcal Infections, Including the Use of Pneumococcal Conjugate Vaccine (Prevnar), Pneumococcal Polysaccharide Vaccine, and Antibiotic ProphylaxisPediatrics, 2000
- Serotype Distribution of Streptococcus pneumoniae Infections among Preschool Children in the United States, 1978-1994: Implications for Development of a Conjugate VaccineThe Journal of Infectious Diseases, 1995
- Infections Caused by Streptococcus pneumoniae: Clinical Spectrum, Pathogenesis, Immunity, and TreatmentClinical Infectious Diseases, 1992